{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:05:13Z","timestamp":1790089513376,"version":"4.0.1"},"reference-count":36,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"V\u00e4sterbotten","award":["RV-1012941"],"award-info":[{"award-number":["RV-1012941"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Amyloid"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/13506129.2026.2678340","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:29:58Z","timestamp":1780478998000},"page":"349-355","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experience"],"prefix":"10.1080","volume":"33","author":[{"given":"John L.","family":"Berk","sequence":"first","affiliation":[{"name":"Boston Medical Center, Boston University","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Carroll","sequence":"additional","affiliation":[{"name":"KJC Statistics Ireland","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mejia Baranda","sequence":"additional","affiliation":[{"name":"Department of Medicine, Pite\u00e5 Hospital","place":["Pite\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Pilebro","sequence":"additional","affiliation":[{"name":"Department of Public Health and Clinical Medicine, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Samuelsson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Karolinska University Hospital","place":["Stockholm, Sweden"]},{"name":"Department of Clinical Neuroscience, Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Eldhagen","sequence":"additional","affiliation":[{"name":"Unit of Cardiology, Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Wixner","sequence":"additional","affiliation":[{"name":"Department of Public Health and Clinical Medicine, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.003"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09688-0"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr383"},{"key":"e_1_3_4_5_1","first-page":"1","article-title":"Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden","volume":"590","author":"Andersson R.","year":"1976","unstructured":"Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl. 1976;590:1\u201364.","journal-title":"Acta Med Scand Suppl"},{"key":"e_1_3_4_6_1","first-page":"88","volume-title":"Forty years of experience with type I amyloid neuropathy. Review of 483 cases. Amyloid and Amyloidosis","author":"Coutinho P","year":"1980","unstructured":"Coutinho P, Martins da Silva A, Lopes Lima J, et al. Forty years of experience with type I amyloid neuropathy. Review of 483 cases. Amyloid and Amyloidosis. Amsterdam: Excerpta Medica; 1980. p. 88\u201398."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006543"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11050545"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(12)60388-7"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2015.1019610"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000574"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182661eb1"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7051-7"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716153"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716793"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2022.2091985"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.045093"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2021.1900738"},{"key":"e_1_3_4_20_1","first-page":"21202","article-title":"[Hereditary transthyretin amyloidosis - from symptomatic to curative treatment?]","volume":"119","author":"Wixner J","year":"2022","unstructured":"Wixner J, Anan I, Pilebro B, et al. [Hereditary transthyretin amyloidosis - from symptomatic to curative treatment?]. Lakartidningen. 2022;119:21202.","journal-title":"Lakartidningen"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.283815"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.07.017"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2014.997872"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2019.1593133"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10143-4"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2021.2000388"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.70020"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/13506129708995279"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1994.tb01106.x"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1053-2498(01)00776-8"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/74.3.646"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10454"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2023.10.016"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.52158"},{"key":"e_1_3_4_36_1","unstructured":"L\u00e4kemedelsbehandling vid \u00e4rftlig transtyretinamyloidos (ATTRv Skelleftesjukan). Sveriges l\u00e4kemedelskommitt\u00e9er; 2025. https:\/\/samverkanlakemedel.se\/natverket-lok\/rekommendationer-fran-lok\/rekommendationer\/2025-10-15-lakemedelsbehandling-vid-arftlig-transtyretinamyloidos-attrv-skelleftesjukan."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199511150-00009"}],"container-title":["Amyloid"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13506129.2026.2678340","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13506129.2026.2678340","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13506129.2026.2678340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:34:32Z","timestamp":1790087672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13506129.2026.2678340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/13506129.2026.2678340"],"URL":"https:\/\/doi.org\/10.1080\/13506129.2026.2678340","relation":{},"ISSN":["1350-6129","1744-2818"],"issn-type":[{"value":"1350-6129","type":"print"},{"value":"1744-2818","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iamy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iamy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}